XJPX3386
Market cap39mUSD
Jan 14, Last price
1,081.00JPY
1D
0.46%
1Q
-11.76%
Jan 2017
-13.86%
IPO
-59.81%
Name
Cosmo Bio Co Ltd
Chart & Performance
P/E
14.22
P/S
0.67
EPS
76.04
Div Yield, %
3.14%
Shrs. gr., 5y
—
Rev. gr., 5y
0.63%
Revenues
9.34b
-2.23%
Net income
442m
-14.51%
CFO
736m
+159.15%
Dividend
Dec 27, 202436 JPY/sh
Profile
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 9,340,000 -2.23% | 9,553,000 3.49% | |||
Cost of revenue | 6,163,000 | 6,194,000 | |||
Unusual Expense (Income) | |||||
NOPBT | 3,177,000 | 3,359,000 | |||
NOPBT Margin | 34.01% | 35.16% | |||
Operating Taxes | 191,000 | 238,000 | |||
Tax Rate | 6.01% | 7.09% | |||
NOPAT | 2,986,000 | 3,121,000 | |||
Net income | 442,000 -14.51% | 517,000 -29.85% | |||
Dividends | (197,000) | (232,000) | |||
Dividend yield | 3.44% | 3.95% | |||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | 20,000 | 20,000 | |||
Long-term debt | 4,000 | 6,000 | |||
Deferred revenue | |||||
Other long-term liabilities | 637,000 | 592,000 | |||
Net debt | (5,773,000) | (5,156,000) | |||
| Cash flow | |||||
Cash from operating activities | 736,000 | 284,000 | |||
CAPEX | (67,000) | (104,000) | |||
Cash from investing activities | (758,000) | (291,000) | |||
Cash from financing activities | (201,000) | (236,000) | |||
FCF | 3,089,000 | 2,739,000 | |||
| Balance | |||||
Cash | 3,025,000 | 3,036,000 | |||
Long term investments | 2,772,000 | 2,146,000 | |||
Excess cash | 5,330,000 | 4,704,350 | |||
Stockholders' equity | 7,957,000 | 7,572,000 | |||
Invested Capital | 4,352,000 | 4,427,650 | |||
ROIC | 68.02% | 71.87% | |||
ROCE | 32.52% | 36.52% | |||
| EV | |||||
Common stock shares outstanding | 5,828 | 5,805 | |||
Price | 983.00 -2.77% | 1,011.00 -12.99% | |||
Market cap | 5,729,398 -2.38% | 5,869,192 -13.05% | |||
EV | 537,398 | 1,278,192 | |||
EBITDA | 3,325,000 | 3,500,000 | |||
EV/EBITDA | 0.16 | 0.37 | |||
Interest | |||||
Interest/NOPBT | |||||